Purchases and Sales Made in Q3 2022 in Connect Biopharma Holdings LTD (CNTB)
This table provides information about the institutional ownership of Connect Biopharma Holdings LTD (CNTB) during Q3 2022. The information is specifically focused on institutions that hold shares of Connect Biopharma Holdings Ltd.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Css LLC
Chicago, IL |
BUY
|
- |
18.7K+ 93.61% |
$15K - $30.9K
|
38.7K
$37.9K
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
16.4K+ 24.51% |
$13.1K - $27.1K
|
83.3K
$81.6K
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
2.82K+ 1118.25% |
$2.25K - $4.65K
|
3.07K
$3.01K
|
|
Oct 17, 2022
Q3 2022
|
Rocky Mountain Advisers, LLC
|
BUY
|
- |
1.2KNew |
$960 - $1.98K
|
1.2K
$1.18K
|
|
Nov 04, 2022
Q3 2022
|
Simplex Trading, LLC
|
BUY
|
- |
903New |
$722 - $1.49K
|
903
$885
|
|
Oct 21, 2022
Q3 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
397New |
$318 - $655
|
397
$389
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
152New |
$122 - $251
|
152
$149
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-64- 0.78% |
$51.2 - $106
|
8.09K
$7.93K
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-409- 81.47% |
$327 - $675
|
93
$91.1
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-615- 3.66% |
$492 - $1.01K
|
16.2K
$15.9K
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-5.96K- 30.62% |
$4.76K - $9.83K
|
13.5K
$13.2K
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-5.96K- 30.62% |
$4.76K - $9.83K
|
13.5K
$13.2K
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-8.53K- 0.59% |
$6.83K - $14.1K
|
1.43M
$1.4M
|
|
Nov 14, 2022
Q3 2022
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-37.6K- 5.77% |
$30.1K - $62K
|
614K
$602K
|
|
Nov 14, 2022
Q3 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-51K- 65.49% |
$40.8K - $84.1K
|
26.9K
$26.3K
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-105K- 99.53% |
$83.8K - $173K
|
496
$486
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-161K- 42.8% |
$129K - $265K
|
215K
$210K
|
|
Nov 14, 2022
Q3 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-400K- 23.84% |
$320K - $660K
|
1.28M
$1.25M
|
|
Nov 14, 2022
Q3 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-458K- 67.62% |
$367K - $756K
|
220K
$215K
|